What Is ARFID? Doctors Explain Why the Eating Disorder’s Rates Are Rising

Scientific American — GlobalWednesday, November 5, 2025 at 12:00:00 PM

What Is ARFID? Doctors Explain Why the Eating Disorder’s Rates Are Rising

Avoidant/restrictive food intake disorder, or ARFID, is gaining attention as its rates rise among both children and adults. This eating disorder leads to malnutrition and weight loss, often without the influence of body image concerns. Understanding ARFID is crucial because it highlights the need for awareness and treatment options for those affected, ensuring they receive the support necessary for recovery.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
TrumpRx News: Why Donald Trump Struck a Deal With Novo Nordisk's Weight Loss Drugs — And What It Says About America's Obesity Problem
PositiveArtificial Intelligence
Donald Trump has made a significant deal with Novo Nordisk to reduce the price of certain GLP-1 weight loss medications to as low as $149 per month, a drastic decrease from the current average price of $1,000 to $1,350. This move is crucial as it addresses America's growing obesity problem, making effective treatments more accessible to those in need. By lowering costs, more individuals may seek help for weight management, potentially leading to healthier lifestyles and reduced healthcare costs in the long run.